Novo Nordisk Boosts Metsera Bid To $10B After Pfizer Suit
By Al Barbarino · November 4, 2025, 3:51 PM EST
Metsera Inc. said Tuesday its board has determined that a sweetened offer from Novo Nordisk is a superior proposal to its existing merger agreement with Pfizer Inc., as the pharmaceutical takeover...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login